<DOC>
	<DOCNO>NCT02864303</DOCNO>
	<brief_summary>Although saliva generally regard one interest biological fluid , fact sample use simple , noninvasive method make interesting alternative cerebrospinal fluid ( CSF ) blood diagnostic purpose . The use salivary diagnostics moreover increase past 10 year , show abundant literature well various clinical trial . Saliva collection well standardized major advantage simple non-invasive . An original study already discuss possible change salivary composition Alzheimer 's disease ( AD ) . The feasibility potential interest measure saliva concentration amyloid peptide report article publish recently . The prospect use saliva early diagnosis monitoring AD thus major interest objective current trial .</brief_summary>
	<brief_title>Use Saliva Alzheimer 's Disease Diagnosis</brief_title>
	<detailed_description>Saliva sample To minimize circadian effect , saliva specimen collect 9:00 11:00 a.m . Prior sample procedure , participant rinse mouth three time water . To induce salivary production , patient ask chew neutral citric acid impregnate Salivette cotton swab exactly 60 second . Saliva specimens centrifuge 2 minute rate 1000 g yield clear saliva , aliquoted 500 µL sample LoBind tube store -80°C analyze . Design study Saliva sampling perform V0 ( M0 ) , V1 ( M12 ) V2 ( M24 ) . Blood sample take place also V1 ( M12 ) . The case control systematically review 12 month inclusion new saliva collection cognitive assessment ( case control ) . Amyloid peptide quantification Levels human endogenous Aβ40 Aβ42 saliva human plasma sample determine human specific enzyme-linked immunosorbent assay ( ELISA ) ( Biosource International , Invitrogen ) , accord manufacturer 's instruction . Briefly , 50 μl saliva plasma sample add triplicate microtiter well . Detection limit assay 6 pg/ml Aβ40 1 pg/ml Aβ42 .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Men/Women ; Aged ≥ 55 year 80 year ; Patients mild cognitive impairment ( MCI ) , answer either criterion normal cognitive functioning criterion insanity , meet criterion diagnosis follow MCI term complete cognitive balance sheet ( assessment ) accord diagnostic procedure publish work group MCI EADC : Mnesic complaint Decline cognitive performance regard previous capacity Cognitive disorder ( confusion ) objectify clinical evaluation ( change memory and/or another cognitive sphere ) The cognitive change echo everyday life Not dementia syndrome Signature inform consent patient ; Subject affiliate national insurance scheme . Edentulous total poor oral hygiene ; Absence sign informed consent ; Clinical laboratory information insufficient unavailable ; Patient deprive freedom , court administrative order ; Major protect law ; Presence contagious viral affection ( HIV , hepatitis B C ) ; Patient include clinical trial ; Patient period relative exclusion regard another protocol annual maximum amount 4500compensations reach .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Saliva</keyword>
	<keyword>Amyloid peptide</keyword>
	<keyword>Diagnosis</keyword>
</DOC>